Alnylam Pharmaceuticals (ALNY) Net profit US GAAP (year values)

2019 2020 2021 2022 2023   LTM ? CAGR 5 years ?
Net profit, bln rub ? -886.1 -858.3 -852.8 -1 131 -440.2   -332.3  
Changes by years, y/y, % +16% -3% -1% +33% -61%     -10.4%

Alnylam Pharmaceuticals. Net profit US GAAP, bln rub

Created with Highcharts 6.0.6-4.1-4.1-25.0-25.0-32.7-32.7-42.9-42.9-34.6-34.6-85.5-85.5-26.2-26.2-47.6-47.6-43.5-43.5-57.6-57.6-106.0-106.0-89.2-89.2-360.4-360.4-290.1-290.1-410.1-410.1-490.9-490.9-761.5-761.5-886.1-886.1-858.3-858.3-852.8-852.8-1131.2-1131.2-440.2-440.2-332.3-332.32002200320042005200620072008200920102011201220132014201520162017201820192020202120222023LTM-1250-1000-750-500-2500smart-lab.ru

Alnylam Pharmaceuticals. Net profit US GAAP, changes, %

Created with Highcharts 6.0.6505.2505.230.430.431.431.4-19.4-19.4147.0147.0-69.3-69.381.381.3-8.6-8.632.532.583.983.9-15.8-15.8303.9303.9-19.5-19.541.441.419.719.755.155.116.416.4-3.1-3.1-0.6-0.632.632.6-61.1-61.1-24.5-24.5200320042005200620072008200920102011201220132014201520162017201820192020202120222023LTM-1000100200300400500600smart-lab.ru

Alnylam Pharmaceuticals. Net profit US GAAP, sum by quarters, bln rub

Created with Highcharts 6.0.6-6.3-6.3-5.7-5.7-14.5-14.5-8.4-8.41.71.7-9.4-9.4-7.8-7.8-6.9-6.9-14.3-14.3-62.2-62.2-32.4-32.4-21.4-21.4-90.7-90.7-112.9-112.9-142.2-142.2-211.4-211.4-276.2-276.2-243.5-243.5-258.5-258.5-207.5-207.5-137.9-137.9-13.6-13.6-6.4-6.4-10.7-10.7-7.4-7.4-52.8-52.8-2.9-2.9-9.2-9.2-9.6-9.6-13.2-13.2-19.5-19.5-29.7-29.7-44.0-44.0-76.8-76.8-104.1-104.1-122.9-122.9-245.3-245.3-208.5-208.5-253.3-253.3-204.5-204.5-405.9-405.9147.8147.8-111.6-111.6-11.1-11.1-9.9-9.9-12.7-12.7-12.8-12.8-22.7-22.7-14.6-14.6-13.8-13.8-13.0-13.0-18.2-18.2-44.1-44.1-71.8-71.8-90.1-90.1-118.4-118.4-163.6-163.6-219.5-219.5-179.2-179.2-189.6-189.6-277.4-277.4-276.0-276.0-16.9-16.9-7.0-7.0-6.6-6.6-8.9-8.9-21.6-21.6-1.2-1.2-7.9-7.9-12.3-12.3-16.3-16.3-11.4-11.4-9.0-9.0-250.9-250.9-50.8-50.8-103.0-103.0-107.3-107.3-141.2-141.2-181.9-181.9-182.2-182.2-200.3-200.3-240.3-240.3-174.1-174.1-65.9-65.94 quarter3 quarter2 quarter1 quarter200320042005200620072008200920102011201220132014201520162017201820192020202120222023202422-1250-1000-750-500-2500250smart-lab.ru

Alnylam Pharmaceuticals (ALNY) Net profit US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
Net profit, bln rub ? 147.8 -137.9 -65.9 -16.9 -111.6   -332.3
Changes by years, y/y, % -136% -34% -62% -94% -176%    
Changes by quarters, q/q, % -154% -193% -52% -74% +561%    

Alnylam Pharmaceuticals. Net profit US GAAP, bln rub

Created with Highcharts 6.0.6-6.3-6.3-13.6-13.6-7.0-7.0-6.4-6.4-5.7-5.7-6.6-6.6-11.1-11.1-10.7-10.7-14.5-14.5-8.9-8.9-9.9-9.9-7.4-7.4-8.4-8.4-21.6-21.6-12.7-12.7-52.8-52.81.71.7-1.2-1.2-12.8-12.8-2.9-2.9-9.4-9.4-7.9-7.9-22.7-22.7-9.2-9.2-7.8-7.8-12.3-12.3-14.6-14.6-9.6-9.6-6.9-6.9-16.3-16.3-13.8-13.8-13.2-13.2-14.3-14.3-11.4-11.4-13.0-13.0-19.5-19.5-62.2-62.2-9.0-9.0-18.2-18.2-29.7-29.7-32.4-32.4-250.9-250.9-44.1-44.1-44.0-44.0-21.4-21.4-50.8-50.8-71.8-71.8-76.8-76.8-90.7-90.7-103.0-103.0-90.1-90.1-104.1-104.1-112.9-112.9-107.3-107.3-118.4-118.4-122.9-122.9-142.2-142.2-141.2-141.2-163.6-163.6-245.3-245.3-211.4-211.4-181.9-181.9-219.5-219.5-208.5-208.5-276.2-276.2-182.2-182.2-179.2-179.2-253.3-253.3-243.5-243.5-200.3-200.3-189.6-189.6-204.5-204.5-258.5-258.5-240.3-240.3-277.4-277.4-405.9-405.9-207.5-207.5-174.1-174.1-276.0-276.0147.8147.8-137.9-137.9-65.9-65.9-16.9-16.9-111.6-111.62003Q42004Q12004Q42005Q22005Q42006Q22006Q42007Q22007Q42008Q22008Q42009Q22009Q42010Q22010Q42011Q22011Q42012Q22012Q42013Q22013Q42014Q22014Q42015Q22015Q42016Q22016Q42017Q22017Q42018Q22018Q42019Q22019Q42020Q22020Q42021Q22021Q42022Q22022Q42023Q22023Q42024Q2-500-400-300-200-1000100200smart-lab.ru

Alnylam Pharmaceuticals. Net profit US GAAP, changes, y/y, %

Created with Highcharts 6.0.6-8.9-8.9-5.1-5.166.466.4154.2154.234.234.2-11.1-11.1-30.7-30.7-41.8-41.8144.3144.328.128.1613.4613.4-119.7-119.7-94.3-94.30.50.5-94.6-94.6-665.1-665.1536.7536.777.977.9222.2222.2-17.0-17.056.256.2-35.5-35.54.64.6-11.1-11.132.232.2-5.5-5.537.537.5106.4106.4-30.2-30.2-6.3-6.347.347.3334.8334.8-20.7-20.740.240.252.252.2-48.0-48.02684.22684.2142.6142.648.248.2-33.9-33.9-79.8-79.862.962.974.674.6324.1324.1102.8102.825.625.635.535.524.524.54.24.231.431.418.118.125.925.931.631.638.138.199.599.548.748.728.828.834.234.2-15.0-15.030.630.60.20.2-18.3-18.321.521.5-11.8-11.89.99.95.85.8-19.3-19.36.16.120.020.046.346.398.598.5-19.7-19.7-27.6-27.6-0.5-0.5-136.4-136.4-33.6-33.6-62.1-62.1-93.9-93.9-175.5-175.52004Q42005Q32006Q12006Q32007Q12007Q32008Q12008Q32009Q12009Q32010Q12010Q32011Q12011Q32012Q12012Q32013Q12013Q32014Q12014Q32015Q12015Q32016Q12016Q32017Q12017Q32018Q12018Q32019Q12019Q32020Q12020Q32021Q12021Q32022Q12022Q32023Q12023Q32024Q12024Q3-1k01k2k3ksmart-lab.ru

Alnylam Pharmaceuticals. Net profit US GAAP, changes, q/q, %

Created with Highcharts 6.0.6117.0117.0-48.8-48.8-7.8-7.8-11.2-11.215.815.868.968.9-4.2-4.235.735.7-38.9-38.911.911.9-25.3-25.314.014.0156.5156.5-41.4-41.4316.0316.0-103.1-103.1-174.5-174.5929.9929.9-77.6-77.6228.6228.6-16.0-16.0187.8187.8-59.4-59.4-15.4-15.458.258.218.718.7-34.2-34.2-28.0-28.0135.0135.0-15.1-15.1-4.2-4.28.18.1-20.5-20.514.014.050.550.5218.9218.9-85.5-85.5101.6101.663.463.49.09.0675.5675.5-82.4-82.4-0.2-0.2-51.4-51.4137.4137.441.441.47.07.018.118.113.513.5-12.5-12.515.515.58.58.5-5.0-5.010.410.43.83.815.715.7-0.7-0.715.815.850.050.0-13.8-13.8-14.0-14.020.720.7-5.0-5.032.432.4-34.0-34.0-1.6-1.641.341.3-3.8-3.8-17.8-17.8-5.4-5.47.97.926.426.4-7.0-7.015.415.446.346.3-48.9-48.9-16.1-16.158.558.5-153.5-153.5-193.3-193.3-52.2-52.2-74.4-74.4560.6560.62004Q32004Q32005Q12005Q32006Q12006Q32007Q12007Q32008Q12008Q32009Q12009Q32010Q12010Q32011Q12011Q32012Q12012Q32013Q12013Q32014Q12014Q32015Q12015Q32016Q12016Q32017Q12017Q32018Q12018Q32019Q12019Q32020Q12020Q32021Q12021Q32022Q12022Q32023Q12023Q32024Q12024Q3-25002505007501000smart-lab.ru